Recent Posts
- Phase 1b trial enrolling to test continuous low-dose lenalidomide
- Aphexda approved in US to improve autologous stem cell transplants
- Some myeloma cells may mutate to resist T-cell therapies: Study
- Spotlight shines on blood cancer this September awareness month
- Elranatamab, now Elrexfio, approved for hard-to-treat myeloma